Physiotherapy Equipment MarketSize, Share & Industry Analysis, 2026-2034By Product TypeBy ApplicationBy End UserBy Level of AutomationBy PortabilityBy Treated Body RegionBy Patient Age GroupBy Distribution ChannelBy Revenue Stream
Full title & scope — all 9 axes with their segments
Physiotherapy Equipment Market Size, Share & Industry Analysis, By Product Type (Electrotherapy Equipment, Therapeutic Ultrasound Equipment, Shockwave Therapy Equipment, Laser and Light Therapy Equipment, Shortwave and Microwave Diathermy, Exercise and Strength Therapy Equipment, Traction Equipment, Thermotherapy and Cryotherapy Equipment, Hydrotherapy Equipment, Continuous Passive Motion Devices), By Application (Musculoskeletal Disorders, Neurological Disorders, Cardiovascular and Pulmonary Rehabilitation, Sports Injuries, Post-Surgical and Orthopedic Rehabilitation, Pain Management, Pediatric Disorders, Women's Health and Pelvic Floor), By End User (Hospitals, Physiotherapy Clinics, Rehabilitation Centers, Sports Clubs and Athletic Facilities, Home Care Settings, Nursing and Long-Term Care Facilities), By Level of Automation (Manual and Mechanical, Electrically Powered, Computer-Controlled and Software-Guided, Robotic and Exoskeleton-Assisted), By Portability (Stationary and Floor-Standing, Portable and Handheld, Wearable), By Treated Body Region (Upper Limb and Shoulder, Lower Limb, Spine and Trunk, Neck and Head, Pelvic Region, Full Body), By Patient Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Direct Sales, Medical Equipment Distributors and Dealers, Online and E-commerce, Tender and Group Purchasing, Rental and Leasing), By Revenue Stream (Capital Equipment, Accessories and Consumables, Software and Digital Platforms, Installation, Service and Maintenance), and Regional Forecast, 2026-2034
Market outlook, key takeaways, drivers and challenges for the report period.
- 01By Product TypeElectrotherapy Equipment · Therapeutic Ultrasound Equipment · Shockwave Therapy Equipment
- 02By ApplicationMusculoskeletal Disorders · Neurological Disorders · Cardiovascular and Pulmonary Rehabilitation
- 03By End UserHospitals · Physiotherapy Clinics · Rehabilitation Centers
- 04By Level of AutomationManual and Mechanical · Electrically Powered · Computer-Controlled and Software-Guided
- 05By PortabilityStationary and Floor-Standing · Portable and Handheld · Wearable
- 06By Treated Body RegionUpper Limb and Shoulder · Lower Limb · Spine and Trunk
- 07By Patient Age GroupPediatric · Adult · Geriatric
- 08By Distribution ChannelDirect Sales · Medical Equipment Distributors and Dealers · Online and E-commerce
- 09By Revenue StreamCapital Equipment · Accessories and Consumables · Software and Digital Platforms
- 10By Region
Market Analysis & Outlook
Physiotherapy equipment covers the devices used to restore movement, reduce pain and rebuild strength in patients with injury, disease or disability. It spans electrotherapy and ultrasound units, shockwave and laser systems, heat and cold devices, exercise and traction equipment, hydrotherapy installations and powered or robotic rehabilitation systems, supplied as stationary clinic units and as portable or wearable products. Buyers include hospitals, physiotherapy clinics, rehabilitation centres, sports facilities, long-term care homes and, increasingly, patients and carers treating at home.
Growth of 5.93% a year carries the global physiotherapy equipment market from USD 22.6 billion in 2025 to USD 37.9 billion in 2034. The full series behind that rate covers USD 17.7 billion in 2020, USD 21.45 billion in 2024, USD 23.9 billion in 2026 and USD 30.1 billion in 2030, with 2025 as the base year.
On the product type axis, growth rates run from 0.64% for Shortwave and Microwave Diathermy up to 10.62% for Shockwave Therapy Equipment. Exercise and Strength Therapy Equipment carries the volume: USD 7.096 billion and 31.4% of revenue in 2025, USD 13.644 billion and 36% in 2034. Share moves toward Shockwave Therapy Equipment, Laser and Light Therapy Equipment, Exercise and Strength Therapy Equipment and Continuous Passive Motion Devices and away from Electrotherapy Equipment, Therapeutic Ultrasound Equipment, Shortwave and Microwave Diathermy, Traction Equipment, Thermotherapy and Cryotherapy Equipment and Hydrotherapy Equipment, though no line shrinks in revenue terms.
Cut by application, the largest line is Musculoskeletal Disorders: 38% of 2025 revenue, worth USD 8.588 billion, and 35% at USD 13.265 billion by 2034. Women's Health and Pelvic Floor grows faster at 10.62% against 4.95%, moving from 2.5% of revenue to 3.7% by 2034. Both this axis and the product type one divide the same revenue, which is why they are alternative views, not components.
The regional order runs from North America at 35% of 2025 revenue down to Middle East and Africa at 6%. North America is worth USD 7.91 billion in 2025 and USD 11.9 billion in 2034; Europe, second at 28%, moves from USD 6.328 billion to USD 9.589 billion. Asia Pacific gain share across the period, so growth is not distributed evenly between regions.
The 2025 total is a triangulation of published figures and category proxies, short of a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, ten product type lines and nine segmentation axes across a fifteen-year window.
Market Size, 2020–2034
USD BillionRevenue in USD Billion. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- Revenue grows from USD 22.6 billion in 2025 to USD 37.9 billion in 2034, a compound annual rate of 5.93%, having reached USD 21.45 billion in 2024 from USD 17.7 billion in 2020.
- The largest line by product type is Exercise and Strength Therapy Equipment, worth USD 7.096 billion and 31.4% of revenue in 2025, rising to USD 13.644 billion and 36% by 2034.
- Shockwave Therapy Equipment is the fastest-growing line at 10.62%, lifting its share from 5.5% in 2025 to 8.2% in 2034 and its revenue from USD 1.243 billion to USD 3.108 billion.
- Scenario range for 2034 runs from USD 33.7 billion in the bear case to USD 42.4 billion in the bull case, against a base-case USD 37.9 billion, the spread a plan built on this forecast has to absorb.
- 35% of 2025 revenue is generated in North America, worth USD 7.91 billion and rising to USD 11.9 billion by 2034; Middle East and Africa is smallest at 6%.
- Within North America, the United States is the worked country example, at USD 6.95 billion in 2025; 87.86% of regional revenue in the base year, and USD 10.45 billion by 2034.
- The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and nine segmentation axes separately, with revenue, share and a growth rate for every line in each year.
Market Trends
Revenue Share, By product type
Base year 2025Exercise and Strength Therapy Equipment leads with 31.4% of product type segment revenue.
Share of product type segment revenue, most recent base year. The 4 smallest segments are grouped as Other.
Read across the forecast period, the global physiotherapy equipment market shows movement in three places: product type composition, regional weight, and the 5.93% rate applied to the whole.
Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.
Composition shifts on the product type axis. Shockwave Therapy Equipment grows at 10.62% across 2026-2034 against 0.64% for Shortwave and Microwave Diathermy, the widest spread on the product type axis. By 2034 the two sit at 8.2% and 3.5% of revenue, against 5.5% and 5.5% in 2025. Revenue rises on both sides; USD 1.243 billion to USD 3.108 billion and USD 1.243 billion to USD 1.327 billion respectively, so this is a change in composition, not a contraction, and one forecast window is long enough for it to matter.
The regional balance moves. Asia Pacific moves from 25% of revenue in 2025 to 31.3% in 2034, worth USD 5.65 billion rising to USD 11.863 billion. The offsetting side is North America at 35% moving to 31.4%, Europe at 28% moving to 25.3%, Latin America at 6% moving to 6%, Middle East and Africa at 6% moving to 6%, none of which contracts. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.
A continuation, not an inflection. Fifteen years of revenue run USD 17.7 billion in 2020, USD 21.45 billion in 2024, USD 22.6 billion in 2025, USD 23.9 billion in 2026, USD 30.1 billion in 2030 and USD 37.9 billion in 2034. No year breaks the trajectory, and the 5.93% forecast rate compares with 5.01% recorded over 2020-2025, a continuation, not an inflection. That moves the planning question away from timing a turn and onto the product type and regional mixes, where the actual movement is.
Market Growth Factors
The fastest line decides the blended rate
Market Drivers
3- 01The fastest line decides the blended rate
The fastest line on the product type axis is Shockwave Therapy Equipment, at 10.62% against the market's 5.93%, taking USD 1.243 billion to USD 3.108 billion and 5.5% of revenue to 8.2%. The market's overall 5.93% depends on that rate holding: at the 0.64% recorded by Shortwave and Microwave Diathermy, the same revenue base would compound to a materially smaller 2034 total. A portfolio weighted away from it tracks below the market even in a market growing everywhere.
- 02North America carries 35% of the base and keeps growing
North America is the largest region at USD 7.91 billion in 2025, 35% of global revenue, and reaches USD 11.9 billion by 2034 while holding 31.4%. Europe adds a further 28% at USD 6.328 billion, reaching USD 9.589 billion. Between them they hold most of the base and most of the revenue added over the period, so equal-weighting the regions in a plan misstates where the growth is.
- 03The trend is already in the record
USD 17.7 billion in 2020, USD 21.45 billion in 2024 and USD 22.6 billion in 2025: 5.01% compound growth before the forecast period even begins. The forecast continues at 5.93% to USD 37.9 billion in 2034. Because the growth is already in the record and not only in the projection, the rate is held flat across the forecast instead of ramped, and the risk in the number sits in the mix assumptions, not in whether the market grows at all.
Growth drivers
| # | Growth driver | Impact | Gross contribution (USD Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Ageing populations and musculoskeletal disease burden | High | +6.2 | High | High | Medium |
| 2 | Rising sports injury and post-surgical rehabilitation volumes | Medium-High | +3.6 | High | Medium | Medium |
| 3 | Shift toward portable and home-based therapy | Medium-High | +3 | Medium | High | High |
| 4 | Adoption of robotic and software-guided rehabilitation | Medium | +2.7 | Low | Medium | High |
| 5 | Clinic and rehabilitation capacity expansion in Asia Pacific | Medium | +1.5 | Medium | Medium | Medium |
| 6 | Others | Low | +1 | Low | Low | Low |
| Total | +18 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (USD Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Reimbursement limits and clinic budget constraints | Medium-High | −1.3 | High | Medium | Medium |
| 2 | High capital cost of robotic and computer-guided systems | Medium | −0.8 | Medium | Medium | Low |
| 3 | Shortage of trained therapists and uneven clinical evidence | Medium | −0.6 | Medium | Medium | Medium |
| Total | −2.7 | |||||
Drivers contribute 18 USD Billion and restraints remove 2.7 USD Billion, a net 15.3 USD Billion, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
Three sources account for the growth to 2034: 5.93% compounding across the base, share moving toward the faster product type lines, and above-market expansion in the leading regions.
Restraining Factors
The bear case and what drives it
Market Restraints
2- 01The bear case and what drives it
A bear case of USD 33.7 billion in 2034, against USD 37.9 billion in the base case, rests on one stated assumption: reimbursement tightens, clinic capital budgets stay constrained, and robotic and computer-guided systems stay limited to specialist centres, so volumes and prices both fall short of the base case. Neither case changes the USD 22.6 billion 2025 base.
- 02The largest line is not the fastest
With 21% of 2025 revenue (USD 4.746 billion) Electrotherapy Equipment is where most of the market sits, and it grows at only 4.44% against the market's 5.93%. Revenue still reaches USD 7.012 billion by 2034 and share still falls to 18.5%: a drag on the average, not a decline.
Market Opportunities
Where the forecast could be beaten
Market Opportunities
2- 01Where the forecast could be beaten
Reimbursement for outpatient and home rehabilitation widens, robotic and wearable systems reach clinics faster, and Asia Pacific clinic capacity grows ahead of plan. On that assumption the market reaches USD 42.4 billion by 2034 against USD 37.9 billion in the base case, from the same USD 22.6 billion in 2025.
- 02Shockwave Therapy Equipment is where share changes hands
Share on the product type axis moves toward Shockwave Therapy Equipment, from 5.5% in 2025 to 8.2% in 2034, on 10.62% growth against the market's 5.93% and revenue rising from USD 1.243 billion to USD 3.108 billion. Taking position there does not require displacing whoever holds Exercise and Strength Therapy Equipment, which is the harder and more expensive fight.
Market Challenges
One product type line carries the market
Market Challenges
2- 01One product type line carries the market
USD 7.096 billion of 2025 revenue sits in Exercise and Strength Therapy Equipment, 31.4% of the total, and it is still 36% at USD 13.644 billion nine years later. Anything that changes demand for it changes the headline number; nothing else on the axis carries that weight.
- 02North America is largely the United States
Of North America's USD 7.91 billion in 2025, USD 6.95 billion (87.86%) comes from the United States alone, rising to USD 10.45 billion by 2034. A regional number that depends this heavily on one country carries that country's specific conditions inside it, which a reader treating the region as diversified would miss.
Segmentation Analysis
9 axesSegmentation runs along nine axes: product type, application, end user, level of automation, portability, treated body region, patient age group, distribution channel and revenue stream. Each axis cuts the same total revenue along a different commercial dimension, so the splits are alternative views of one market, not additions to it.
All ten product type lines expand in revenue terms over the forecast period. Share is the dividing line; four take it, the others cede it.
By Product Type · 10 segments
By Product Type
- Largest Exercise and Strength Therapy Equipment · 31.4%
- Fastest Shockwave Therapy Equipment · 10.6%
- Moves most Exercise and Strength Therapy Equipment · +4.6 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Electrotherapy Equipment | $4.75B | 21% | $7.01B | 18.5%-2.5 | 4.4% |
| Therapeutic Ultrasound Equipment | $1.81B | 8% | $2.58B | 6.8%-1.2 | 4% |
| Shockwave Therapy Equipment | $1.24B | 5.5% | $3.11B | 8.2%+2.7 | 10.6% |
| Laser and Light Therapy Equipment | $1.54B | 6.8% | $3.11B | 8.2%+1.4 | 8.1% |
| Shortwave and Microwave Diathermy | $1.24B | 5.5% | $1.33B | 3.5%-2 | 0.6% |
| Exercise and Strength Therapy Equipment | $7.10B | 31.4% | $13.64B | 36%+4.6 | 7.5% |
| Traction Equipment | $1.13B | 5% | $1.44B | 3.8%-1.2 | 2.7% |
| Thermotherapy and Cryotherapy Equipment | $1.92B | 8.5% | $2.58B | 6.8%-1.7 | 3.3% |
| Hydrotherapy Equipment | $1.08B | 4.8% | $1.52B | 4%-0.8 | 3.8% |
| Continuous Passive Motion Devices | $0.79B | 3.5% | $1.59B | 4.2%+0.7 | 8.1% |
2025 to 2034 revenue and share by line: Exercise and Strength Therapy Equipment USD 7.096 billion to USD 13.644 billion (31.4% in 2025), Electrotherapy Equipment USD 4.746 billion to USD 7.012 billion (21% in 2025), Thermotherapy and Cryotherapy Equipment USD 1.921 billion to USD 2.577 billion (8.5% in 2025), Therapeutic Ultrasound Equipment USD 1.808 billion to USD 2.577 billion (8% in 2025), Laser and Light Therapy Equipment USD 1.537 billion to USD 3.108 billion (6.8% in 2025), Shockwave Therapy Equipment USD 1.243 billion to USD 3.108 billion (5.5% in 2025), Shortwave and Microwave Diathermy USD 1.243 billion to USD 1.327 billion (5.5% in 2025), Traction Equipment USD 1.13 billion to USD 1.44 billion (5% in 2025), Hydrotherapy Equipment USD 1.085 billion to USD 1.516 billion (4.8% in 2025), Continuous Passive Motion Devices USD 0.791 billion to USD 1.592 billion (3.5% in 2025). Shockwave Therapy Equipment Outpaces the Axis While Exercise and Strength Therapy Equipment Holds the Largest Share Exercise and strength therapy equipment leads because almost every rehabilitation programme ends in active loading, so every clinic buys it and replaces it on a long cycle. Shockwave therapy is growing fastest from a small base, helped by wider clinical acceptance for tendon and soft tissue conditions, reimbursement in some systems and demand from sports medicine practices that can charge a premium per session. The order does not change: Exercise and Strength Therapy Equipment is still largest in 2034, and what moves is how much it holds. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.
By Application · 8 segments
By Application
- Largest Musculoskeletal Disorders · 38%
- Fastest Women's Health and Pelvic Floor · 10.6%
- Moves most Musculoskeletal Disorders · -3 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Musculoskeletal Disorders | $8.59B | 38% | $13.27B | 35%-3 | 5% |
| Neurological Disorders | $3.16B | 14% | $6.25B | 16.5%+2.5 | 7.9% |
| Cardiovascular and Pulmonary Rehabilitation | $1.70B | 7.5% | $3.03B | 8%+0.5 | 6.7% |
| Sports Injuries | $2.71B | 12% | $4.55B | 12% | 5.9% |
| Post-Surgical and Orthopedic Rehabilitation | $3.28B | 14.5% | $5.31B | 14%-0.5 | 5.5% |
| Pain Management | $2.03B | 9% | $3.03B | 8%-1 | 4.5% |
| Pediatric Disorders | $0.56B | 2.5% | $1.06B | 2.8%+0.3 | 7.3% |
| Women's Health and Pelvic Floor | $0.56B | 2.5% | $1.40B | 3.7%+1.2 | 10.6% |
2025 to 2034 revenue and share by line: Musculoskeletal Disorders USD 8.588 billion to USD 13.265 billion (38% to 35%), Post-Surgical and Orthopedic Rehabilitation USD 3.277 billion to USD 5.306 billion (14.5% to 14%), Neurological Disorders USD 3.164 billion to USD 6.254 billion (14% to 16.5%), Sports Injuries USD 2.712 billion to USD 4.548 billion (12% to 12%), Pain Management USD 2.034 billion to USD 3.032 billion (9% to 8%), Cardiovascular and Pulmonary Rehabilitation USD 1.695 billion to USD 3.032 billion (7.5% to 8%), Pediatric Disorders USD 0.565 billion to USD 1.061 billion (2.5% to 2.8%), Women's Health and Pelvic Floor USD 0.565 billion to USD 1.402 billion (2.5% to 3.7%). Scale in Musculoskeletal Disorders and Growth in Women's Health and Pelvic Floor Define the Application Axis Musculoskeletal disorders lead because back, joint and soft tissue complaints are the most common reason patients are referred to physiotherapy, and they drive recurring treatment visits. Women's health and pelvic floor is growing fastest as awareness has risen, stigma has eased and dedicated devices have moved from specialist units into general clinics and home use. The order does not change: Musculoskeletal Disorders is still largest in 2034, and what moves is how much it holds.
By End User · 6 segments
Physiotherapy Clinics Held the Dominant Share of the End user Segment in 2025
- Largest Physiotherapy Clinics · 33%
- Fastest Home Care Settings · 11.2%
- Moves most Home Care Settings · +6 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Hospitals | $6.10B | 27% | $9.10B | 24%-3 | 4.5% |
| Physiotherapy Clinics | $7.46B | 33% | $11.37B | 30%-3 | 4.8% |
| Rehabilitation Centers | $3.62B | 16% | $6.06B | 16% | 5.9% |
| Sports Clubs and Athletic Facilities | $1.36B | 6% | $2.27B | 6% | 5.9% |
| Home Care Settings | $2.49B | 11% | $6.44B | 17%+6 | 11.2% |
| Nursing and Long-Term Care Facilities | $1.58B | 7% | $2.65B | 7% | 5.9% |
Physiotherapy clinics lead because they carry the largest number of treatment sessions and are the main buyers of modular electrotherapy, ultrasound and laser units. Home care settings grow fastest as portable and wearable devices, shorter hospital stays and tele-rehabilitation programmes move part of the course of treatment out of the clinic and into the patient's residence. By 2034 Physiotherapy Clinics is still ahead, making this a shift in weight, not a change of leader.
By Level of Automation · 4 segments
Electrically Powered Led by Level of automation in 2025, with Robotic and Exoskeleton-Assisted Growing Fastest
- Largest Electrically Powered · 52%
- Fastest Robotic and Exoskeleton-Assisted · 14.4%
- Moves most Manual and Mechanical · -8 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Manual and Mechanical | $6.33B | 28% | $7.58B | 20%-8 | 2% |
| Electrically Powered | $11.75B | 52% | $18.95B | 50%-2 | 5.5% |
| Computer-Controlled and Software-Guided | $3.84B | 17% | $9.10B | 24%+7 | 10.1% |
| Robotic and Exoskeleton-Assisted | $0.68B | 3% | $2.27B | 6%+3 | 14.4% |
Electrically powered equipment leads because it covers the standard clinic modalities, from stimulators to ultrasound and shockwave units, at a price most practices can fund. Robotic and exoskeleton-assisted systems are growing fastest as neurological rehabilitation centres adopt them for high-repetition gait and arm training, and as prices fall and evidence of functional gains builds. By 2034 Electrically Powered is still ahead, making this a shift in weight, not a change of leader.
By Portability · 3 segments
Stationary and Floor-Standing Led by Portability in 2025, with Wearable Growing Fastest
- Largest Stationary and Floor-Standing · 62%
- Fastest Wearable · 13.1%
- Moves most Stationary and Floor-Standing · -10 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Stationary and Floor-Standing | $14.01B | 62% | $19.71B | 52%-10 | 3.9% |
| Portable and Handheld | $7.46B | 33% | $14.78B | 39%+6 | 7.9% |
| Wearable | $1.13B | 5% | $3.41B | 9%+4 | 13.1% |
Stationary and floor-standing equipment leads because treatment tables, exercise stations, traction frames and hydrotherapy units are fixed installations in clinics and hospitals. Wearable devices grow fastest as sensors, battery life and stimulation electronics improve, letting patients continue therapy between visits and giving clinicians data on adherence that a fixed machine cannot supply. The order does not change: Stationary and Floor-Standing is still largest in 2034, and what moves is how much it holds.
By Treated Body Region · 6 segments
Pelvic Region Outpaces the Axis While Lower Limb Holds the Largest Share
- Largest Lower Limb · 28%
- Fastest Pelvic Region · 9.9%
- Moves most Pelvic Region · +2 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Upper Limb and Shoulder | $5.42B | 24% | $8.72B | 23%-1 | 5.4% |
| Lower Limb | $6.33B | 28% | $10.23B | 27%-1 | 5.5% |
| Spine and Trunk | $5.88B | 26% | $9.47B | 25%-1 | 5.5% |
| Neck and Head | $1.81B | 8% | $3.03B | 8% | 5.9% |
| Pelvic Region | $1.13B | 5% | $2.65B | 7%+2 | 9.9% |
| Full Body | $2.03B | 9% | $3.79B | 10%+1 | 7.2% |
Lower limb treatment leads because knee, hip and ankle problems combine high prevalence with long rehabilitation courses after surgery and injury, and gait and balance work needs the most equipment. The pelvic region is growing fastest as pelvic floor care becomes a routine service and purpose-built devices reach clinics and homes. The order does not change: Lower Limb is still largest in 2034, and what moves is how much it holds.
By Patient Age Group · 3 segments
Adult Led by Patient age group in 2025, with Geriatric Growing Fastest
- Largest Adult · 55%
- Fastest Geriatric · 8.1%
- Moves most Adult · -8 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Pediatric | $1.13B | 5% | $1.90B | 5% | 5.9% |
| Adult | $12.43B | 55% | $17.81B | 47%-8 | 4.1% |
| Geriatric | $9.04B | 40% | $18.19B | 48%+8 | 8.1% |
Adults are the largest group because working-age injuries, sports participation, post-surgical rehabilitation and occupational conditions bring the highest number of treated patients through clinics. Geriatric patients are growing fastest as populations age and degenerative joint disease, stroke recovery and falls prevention concentrate in older people who need longer courses of care and more support at home. By 2034 the largest line is Geriatric and no longer Adult, the one axis here where the order actually changes.
By Distribution Channel · 5 segments
Direct Sales Held the Dominant Share of the Distribution channel Segment in 2025
- Largest Direct Sales · 40%
- Fastest Rental and Leasing · 12.7%
- Moves most Direct Sales · -5 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Direct Sales | $9.04B | 40% | $13.27B | 35%-5 | 4.3% |
| Medical Equipment Distributors and Dealers | $8.14B | 36% | $12.51B | 33%-3 | 4.9% |
| Online and E-commerce | $1.81B | 8% | $4.93B | 13%+5 | 11.8% |
| Tender and Group Purchasing | $2.71B | 12% | $4.55B | 12% | 5.9% |
| Rental and Leasing | $0.90B | 4% | $2.65B | 7%+3 | 12.7% |
Direct sales lead because capital equipment is specified, demonstrated and financed through manufacturer sales teams, and hospital and large-clinic buyers expect training and service agreements from the supplier. Rental and leasing grows fastest as small practices avoid upfront capital, and online channels are growing nearly as quickly for accessories and compact devices that need little installation. The order does not change: Direct Sales is still largest in 2034, and what moves is how much it holds.
By Revenue Stream · 4 segments
Capital Equipment Led by Revenue stream in 2025, with Software and Digital Platforms Growing Fastest
- Largest Capital Equipment · 68%
- Fastest Software and Digital Platforms · 15.9%
- Moves most Capital Equipment · -6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Capital Equipment | $15.37B | 68% | $23.50B | 62%-6 | 4.8% |
| Accessories and Consumables | $3.84B | 17% | $6.06B | 16%-1 | 5.2% |
| Software and Digital Platforms | $0.90B | 4% | $3.41B | 9%+5 | 15.9% |
| Installation, Service and Maintenance | $2.49B | 11% | $4.93B | 13%+2 | 7.9% |
Capital equipment leads because each clinic or ward buys the machines first and replaces them only after many years, and the machines carry the highest unit prices. Software and digital platforms grow fastest from a small base as exercise-prescription, remote monitoring and outcome-tracking subscriptions are added to equipment that was previously sold as hardware alone. The order does not change: Capital Equipment is still largest in 2034, and what moves is how much it holds.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The largest region covered — 3.6 points of share move elsewhere by 2034.
- Rank 1 of 5
- 2025 share 35%
- By 2034 31.4%
- Revenue $7.91B → $11.90B
In North America, 35% of global revenue puts 2025 at USD 7.91 billion rising to USD 11.9 billion in 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.
Share settles at 31.4% in 2034, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
The product type mix reported at global level applies here, with Exercise and Strength Therapy Equipment the largest line at 31.4% of 2025 revenue and Shockwave Therapy Equipment the fastest-growing at 10.62%. Revenue for North America is broken out by every segmentation axis and by country in the full report.
United States
Sets the pace for North America at 87.9% of it, growing 1.5×.
- In region 1 of 2
- Of region 87.9%
- Of global 30.8%
- Revenue $6.95B → $10.45B
USD 6.95 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 10.45 billion by 2034. At 87.86% of regional revenue in the base year it is not one market among several, the region's trajectory is largely this country's trajectory. The region itself runs USD 7.91 billion to USD 11.9 billion over the same period, and this is the market carrying the country-level detail in the full report.
The product type pattern in the United States is the global one: 31.4% of 2025 revenue in Exercise and Strength Therapy Equipment, 36% by 2034, against 10.62% growth in Shockwave Therapy Equipment taking it from 5.5% to 8.2%. Since 87.86% of North America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. The full report reports the United States by product type separately.
The Food and Drug Administration regulates physiotherapy equipment as a medical device under the Federal Food, Drug, and Cosmetic Act. Most items, such as exercise apparatus, hot and cold packs and manual therapy aids, fall in the lowest risk class and are often exempt from premarket review. Powered units including electrical stimulators, therapeutic ultrasound and traction devices usually need premarket notification, in which the supplier shows equivalence to a legally marketed device. Suppliers must register their establishment, list their devices, follow the Quality Management System Regulation, report adverse events and meet the agency's labelling requirements. Recognised consensus standards for electrical safety and electromagnetic compatibility support the submission.
Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG and HMS Medical Systems are the suppliers covered in the United States. Exercise and Strength Therapy Equipment, at 31.4% of 2025 revenue, is where the volume sits, and Shockwave Therapy Equipment, growing at 10.62%, is where position changes hands over the forecast period. Country-level shares and positioning per company sit in the full report.
Canada
2nd-largest in North America, growing 1.5×.
- In region 2 of 2
- Of region 7.8%
- Of global 2.7%
- Revenue $0.62B → $0.95B
2.74% of global revenue is generated in Canada; USD 0.62 billion in 2025, reaching USD 0.95 billion in 2034, and 7.84% of North America.
Europe Market Analysis
The 2nd-largest region covered — 2.7 points of share move elsewhere by 2034.
- Rank 2 of 5
- 2025 share 28%
- By 2034 25.3%
- Revenue $6.33B → $9.59B
USD 6.328 billion of 2025 revenue is generated in Europe, 28% of the global physiotherapy equipment market and reaches USD 9.589 billion by 2034. It is a leading region on this axis, second by revenue throughout the period.
Its share moves to 25.3% by 2034, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
The product type mix reported at global level applies here, with Exercise and Strength Therapy Equipment the largest line at 31.4% of 2025 revenue and Shockwave Therapy Equipment the fastest-growing at 10.62%. Per-axis and per-country detail for Europe sits in the full report.
Germany
The largest market in Europe, growing 1.4×.
- In region 1 of 3
- Of region 24.5%
- Of global 6.9%
- Revenue $1.55B → $2.20B
The largest single market in Europe is Germany, at USD 1.55 billion in 2025 and USD 2.2 billion in 2034. It accounts for 24.49% of regional revenue in the base year, the largest single share without dominating the region outright. Set against USD 6.328 billion and USD 9.589 billion for the region, it is why this market, and not a smaller one, is the one reported in full.
Composition here matches the global split: the largest line is Exercise and Strength Therapy Equipment at 31.4% of 2025 revenue, easing to 36% by 2034, and the fastest is Shockwave Therapy Equipment at 10.62%, from 5.5% to 8.2%. Its 24.49% weight in Europe means those movements carry straight into the regional totals. The full report reports Germany by product type separately.
Physiotherapy equipment sold in Germany falls under the European Union Medical Device Regulation, applied nationally through the Medical Devices Implementation Act. The Federal Institute for Drugs and Medical Devices oversees the market, while conformity assessment is carried out by notified bodies designated at European level. Manufacturers classify each product by risk. Simple mechanical aids sit in the lowest class and are self-certified, whereas powered electrotherapy, ultrasound and laser devices need a notified body to review the technical documentation and quality system. Compliant products carry the CE mark, unique device identification and multilingual instructions. Suppliers must also run post-market surveillance, vigilance reporting and registration in the European device database.
The suppliers tracked in this study (Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG and HMS Medical Systems) compete in Germany across the product type lines above. Volume sits in Exercise and Strength Therapy Equipment at 31.4% of 2025 revenue; movement sits in Shockwave Therapy Equipment at 10.62% growth. A supplier weighted toward Europe is competing over a base of USD 6.328 billion in 2025 reaching USD 9.589 billion by 2034, 28% of global revenue at the start of that period.
United Kingdom
2nd-largest in Europe, growing 1.4×.
- In region 2 of 3
- Of region 15.8%
- Of global 4.4%
- Revenue $1B → $1.45B
Within Europe, the United Kingdom accounts for 15.8% of regional revenue and 4.42% of the global total, worth USD 1 billion in 2025 and USD 1.45 billion by 2034.
France
3rd-largest in Europe, growing 1.5×.
- In region 3 of 3
- Of region 13.4%
- Of global 3.8%
- Revenue $0.85B → $1.25B
3.76% of global revenue is generated in France; USD 0.85 billion in 2025, reaching USD 1.25 billion in 2034, and 13.43% of Europe.
Asia Pacific Market Analysis
The 3rd-largest region covered, and the one gaining the most — it picks up 6.3 points of share by 2034, while revenue still grows 2.1×.
- Rank 3 of 5
- 2025 share 25%
- By 2034 31.3%
- Revenue $5.65B → $11.86B
25% of the global physiotherapy equipment market sits in Asia Pacific in 2025, worth USD 5.65 billion and reaches USD 11.863 billion by 2034. That makes it the third-largest region covered, in 2025 and again in 2034.
Share climbs to 31.3% by 2034, so the region grows faster than the market's 5.93% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
The product type mix reported at global level applies here, with Exercise and Strength Therapy Equipment the largest line at 31.4% of 2025 revenue and Shockwave Therapy Equipment the fastest-growing at 10.62%. Revenue for Asia Pacific is broken out by every segmentation axis and by country in the full report.
China
The largest market in Asia Pacific, growing 2.3×.
- In region 1 of 3
- Of region 32.7%
- Of global 8.2%
- Revenue $1.85B → $4.20B
32.74% of Asia Pacific's base-year revenue comes from China; USD 1.85 billion, rising to USD 4.2 billion by 2034. Its 32.74% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Regional revenue of USD 5.65 billion in 2025 and USD 11.863 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
Composition here matches the global split: the largest line is Exercise and Strength Therapy Equipment at 31.4% of 2025 revenue, easing to 36% by 2034, and the fastest is Shockwave Therapy Equipment at 10.62%, from 5.5% to 8.2%. Because the country carries 32.74% of Asia Pacific, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-product type revenue for China appears on its own in the full report.
The National Medical Products Administration regulates physiotherapy equipment under the Regulations on the Supervision and Administration of Medical Devices. Devices are sorted into three classes by risk. Low-risk items are filed with the local authority, while higher-risk powered therapy equipment requires product registration backed by testing at an authorised laboratory and, for many categories, clinical evaluation. Overseas suppliers must appoint a registered agent within China and hold approval from their home market in many cases. Products must comply with mandatory national and industry standards for safety and electromagnetic compatibility, and labels and instructions must appear in Chinese. Manufacturers are also subject to quality system inspections and adverse event monitoring.
In China the field is Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG and HMS Medical Systems. Exercise and Strength Therapy Equipment, at 31.4% of 2025 revenue, is where the volume sits, and Shockwave Therapy Equipment, growing at 10.62%, is where position changes hands over the forecast period. The commercial size of that position is USD 5.65 billion in 2025 and USD 11.863 billion by 2034, 25% of the global total in the base year.
Japan
2nd-largest in Asia Pacific, growing 1.5×.
- In region 2 of 3
- Of region 23%
- Of global 5.8%
- Revenue $1.30B → $1.95B
5.75% of global revenue is generated in Japan; USD 1.3 billion in 2025, reaching USD 1.95 billion in 2034, and 23.01% of Asia Pacific.
India
3rd-largest in Asia Pacific, growing 3.3×.
- In region 3 of 3
- Of region 8%
- Of global 2%
- Revenue $0.45B → $1.50B
India is sized at USD 0.45 billion in 2025, rising to USD 1.5 billion by 2034; 1.99% of global revenue and 7.96% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
Latin America Market Analysis
The 4th-largest region covered, holding its share flat through 2034, while revenue still grows 1.7×.
- Rank 4 of 5
- 2025 share 6%
- By 2034 6%
- Revenue $1.36B → $2.27B
USD 1.356 billion of 2025 revenue is generated in Latin America, 6% of the global physiotherapy equipment market rising to USD 2.274 billion in 2034. That makes it the fourth-largest region covered, in 2025 and again in 2034.
Its share moves to 6% by 2034, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
Within the region the product type split tracks the global one; 31.4% of 2025 revenue in Exercise and Strength Therapy Equipment, fastest growth of 10.62% in Shockwave Therapy Equipment. Per-axis and per-country detail for Latin America sits in the full report.
Brazil
The largest market in Latin America, growing 1.7×.
- In region 1 of 2
- Of region 40.6%
- Of global 2.4%
- Revenue $0.55B → $0.95B
Brazil is the largest market within Latin America, generating USD 0.55 billion in 2025 and projected to reach USD 0.95 billion by 2034. 40.56% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 1.356 billion in 2025 and USD 2.274 billion in 2034, it is the country the full report breaks out in detail.
The product type pattern in Brazil is the global one: 31.4% of 2025 revenue in Exercise and Strength Therapy Equipment, 36% by 2034, against 10.62% growth in Shockwave Therapy Equipment taking it from 5.5% to 8.2%. Since 40.56% of Latin America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-product type revenue for Brazil appears on its own in the full report.
The national health surveillance agency, Anvisa, regulates physiotherapy equipment as a health product. Devices are grouped into risk classes. The lowest classes follow a notification route, while higher-risk powered equipment requires full registration with technical documentation. Foreign manufacturers must be represented by a local registration holder, and manufacturing sites generally need a certificate of good manufacturing practices issued under the agency's rules. Electrically powered devices must also be certified under the national conformity assessment system, which relies on accredited bodies and the technical standards for electrical medical equipment. Labels and instructions for use must be in Portuguese, and suppliers must run post-market monitoring and report adverse events.
The suppliers tracked in this study (Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG and HMS Medical Systems) compete in Brazil across the product type lines above. Volume sits in Exercise and Strength Therapy Equipment at 31.4% of 2025 revenue; movement sits in Shockwave Therapy Equipment at 10.62% growth. A supplier weighted toward Latin America is competing over a base of USD 1.356 billion in 2025, reaching USD 2.274 billion by 2034 on the trajectory this study models.
Mexico
2nd-largest in Latin America, growing 1.8×.
- In region 2 of 2
- Of region 22.9%
- Of global 1.4%
- Revenue $0.31B → $0.55B
Within Latin America, Mexico accounts for 22.86% of regional revenue and 1.37% of the global total, worth USD 0.31 billion in 2025 and USD 0.55 billion by 2034.
Middle East and Africa Market Analysis
The 5th-largest region covered, holding its share flat through 2034, while revenue still grows 1.7×.
- Rank 5 of 5
- 2025 share 6%
- By 2034 6%
- Revenue $1.36B → $2.27B
In Middle East and Africa, 6% of global revenue puts 2025 at USD 1.356 billion on the way to USD 2.274 billion by 2034. By revenue it sits fifth across the study, and the ranking does not change between 2025 and 2034.
Its share moves to 6% by 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
Within the region the product type split tracks the global one; 31.4% of 2025 revenue in Exercise and Strength Therapy Equipment, fastest growth of 10.62% in Shockwave Therapy Equipment. Per-axis and per-country detail for Middle East and Africa sits in the full report.
Saudi Arabia
The largest market in Middle East and Africa, growing 2.0×.
- In region 1 of 2
- Of region 18.4%
- Of global 1.1%
- Revenue $0.25B → $0.50B
USD 0.25 billion of Middle East and Africa's 2025 revenue is generated in Saudi Arabia, the region's largest market, reaching USD 0.5 billion by 2034. Its 18.44% of base-year regional revenue leads the region, though enough sits elsewhere that Middle East and Africa is not a proxy for it. Against regional totals of USD 1.356 billion in 2025 and USD 2.274 billion in 2034, it is the country the full report breaks out in detail.
Composition here matches the global split: the largest line is Exercise and Strength Therapy Equipment at 31.4% of 2025 revenue, easing to 36% by 2034, and the fastest is Shockwave Therapy Equipment at 10.62%, from 5.5% to 8.2%. Because the country carries 18.44% of Middle East and Africa, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by product type for Saudi Arabia is reported separately in the full report.
The Saudi Food and Drug Authority regulates physiotherapy equipment under its medical devices interim regulation. Devices are classified by risk, and manufacturers must obtain a marketing authorisation before products are sold. Overseas suppliers need an authorised representative licensed in the Kingdom, and the establishment itself must hold a licence to import and distribute. The authority generally relies on prior approval from recognised regulators such as those in the United States, European Union, Japan, Canada or Australia to support the submission, together with technical documentation and evidence of a quality management system. Labelling must include Arabic information, and suppliers are required to report adverse events and carry out field safety corrective actions through the authority's vigilance system.
Competition in Saudi Arabia runs between the suppliers this study tracks: Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG and HMS Medical Systems. Exercise and Strength Therapy Equipment, at 31.4% of 2025 revenue, is where the volume sits, and Shockwave Therapy Equipment, growing at 10.62%, is where position changes hands over the forecast period. A supplier weighted toward Middle East and Africa is competing over a base of USD 1.356 billion in 2025, reaching USD 2.274 billion by 2034 on the trajectory this study models.
United Arab Emirates
2nd-largest in Middle East and Africa, growing 1.9×.
- In region 2 of 2
- Of region 12.5%
- Of global 0.8%
- Revenue $0.17B → $0.32B
The United Arab Emirates is sized at USD 0.17 billion in 2025, rising to USD 0.32 billion by 2034; 0.75% of global revenue and 12.54% of Middle East and Africa. It is reported separately from Saudi Arabia across every segmentation axis in the full report.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by product type, application, end user, level of automation, portability, treated body region, patient age group, distribution channel, revenue stream, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Scale in Exercise and Strength Therapy Equipment and Growth in Shockwave Therapy Equipment Set the Terms of Competition
The study covers the following suppliers: Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG and HMS Medical Systems.
Where suppliers actually compete is along the product type axis. Volume sits in Exercise and Strength Therapy Equipment, USD 7.096 billion and 31.4% of 2025 revenue, 36% by 2034, which is also where an incumbent is hardest to dislodge. Shockwave Therapy Equipment, compounding at 10.62% against 0.64% for Shortwave and Microwave Diathermy, is where share changes hands over the forecast period. A supplier positioned in one is not automatically positioned in the other, so a field of this size stays viable in a market of USD 22.6 billion.
Suppliers separate on regulatory clearance across the main markets, on the breadth of clinical evidence behind each modality, and on the service network that keeps equipment working after installation. The largest players hold broad portfolios that let a hospital or clinic buy several modalities from one supplier, with financing and rental terms, training programmes and established distributor networks. Smaller and regional suppliers compete on price in a single modality, on local service response, on designs for a particular body region or patient group, and on tender relationships in their home country. Software and data capabilities are becoming a further point of difference, especially for guided exercise and remote monitoring.
Presence matters unevenly by region. With 35% of 2025 revenue in North America and 28% in Europe, a supplier's coverage of those two decides most of its addressable base before any product question arises.
Company-level profiles, financials, shares and development histories are held in the full report and not in this summary.
List of Key Physiotherapy Equipment Market Companies Profiled
26 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Enovis Corporation(United States)
- BTL Industries
- Zimmer MedizinSysteme GmbH(Germany)
- Performance Health(United States)
- Dynatronics Corporation(United States)
- Zynex, Inc.(United States)
- Storz Medical AG(Switzerland)
- DIH Holding US, Inc.(United States)
- Bioventus Inc.(United States)
- Ekso Bionics Holdings, Inc.(United States)
- ReWalk Robotics Ltd.(Israel)
- Cyberdyne Inc.(Japan)
- Ottobock SE & Co. KGaA(Germany)
- Enraf-Nonius B.V.(Netherlands)
- Gymna Uniphy NV(Belgium)
- Henley Healthcare, Inc.(United States)
- Richmar (Chattanooga Group affiliate / Richmar Corp.)(United States)
- Mettler Electronics Corp.(United States)
- EMS Physio Ltd.(United Kingdom)
- ITO Co., Ltd.(Japan)
- Omron Healthcare Co., Ltd.(Japan)
- HIVAMAT / Deleo Physiotherapie GmbH(Germany)
- Hydroworx International, Inc.(United States)
- Fabrication Enterprises, Inc.(United States)
- Physiomed Elektromedizin AG(Germany)
- HMS Medical Systems
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 9 axes (Product Type, Application, End User, Level of Automation, Portability, Treated Body Region, Patient Age Group, Distribution Channel, Revenue Stream), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 26 key companies, and the research methodology behind every estimate.
Segmentation
9 axes + regionQuestions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Physiotherapy Equipment Market projected to reach?
USD 37.9 USD Billion by 2034, CAGR 5.93%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 35% of global revenue through 2034.
05Which segment leads the market?
Exercise and Strength Therapy Equipment is the largest line by product type, at 31.4% of revenue in 2025.
06Who are the key companies profiled?
Enovis Corporation, BTL Industries, Zimmer MedizinSysteme GmbH, Performance Health, Dynatronics Corporation, Zynex, Inc., Storz Medical AG, DIH Holding US, Inc., Bioventus Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., Ottobock SE & Co. KGaA, Enraf-Nonius B.V., Gymna Uniphy NV, Henley Healthcare, Inc., Richmar (Chattanooga Group affiliate / Richmar Corp.), Mettler Electronics Corp., EMS Physio Ltd., ITO Co., Ltd., Omron Healthcare Co., Ltd., HIVAMAT / Deleo Physiotherapie GmbH, Hydroworx International, Inc., Fabrication Enterprises, Inc., Physiomed Elektromedizin AG, HMS Medical Systems. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.